Teva Pharmaceutical Industries Ltd financial data

Symbol
TEVA on NYSE, TEVJF on OTC
Industry
Pharmaceutical Preparations
Location
Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi'a St., Tel Aviv, Israel
State of incorporation
Israel
Fiscal year end
December 31
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (to 1/16/2001)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 98 % -7.72%
Quick Ratio 32.7 % -8.35%
Debt-to-equity 489 % +16%
Return On Equity -6.24 % +66.8%
Return On Assets -1.12 % +71.1%
Operating Margin 1.42 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.13 B shares +1.09%
Entity Public Float 8.38 B USD +14.8%
Common Stock, Value, Issued 58 M USD +1.75%
Weighted Average Number of Shares Outstanding, Basic 1.12 B shares +0.72%
Weighted Average Number of Shares Outstanding, Diluted 1.12 B shares +0.72%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16 B USD +7.23%
Research and Development Expense 98 M USD
Selling and Marketing Expense 2.4 B USD +7.68%
General and Administrative Expense 1.14 B USD -3.05%
Operating Income (Loss) 228 M USD -1577%
Nonoperating Income (Expense) -1.05 B USD -8.16%
Income Tax Expense (Benefit) -40 M USD +94%
Net Income (Loss) Attributable to Parent -478 M USD +72.1%
Earnings Per Share, Basic -0.42 USD/shares +72.9%
Earnings Per Share, Diluted -0.42 USD/shares +72.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.99 B USD +39.6%
Accounts Receivable, after Allowance for Credit Loss, Current 3.46 B USD +0.61%
Inventory, Net 3.95 B USD -4.1%
Other Assets, Current 495 M USD -8.67%
Assets, Current 12.3 B USD +6.92%
Deferred Income Tax Assets, Net 1.96 B USD +24.3%
Property, Plant and Equipment, Net 5.62 B USD -2.31%
Operating Lease, Right-of-Use Asset 364 M USD -13.3%
Goodwill 17 B USD -4.45%
Other Assets, Noncurrent 470 M USD +4.44%
Assets 42.8 B USD -1.58%
Employee-related Liabilities, Current 492 M USD +13.9%
Liabilities, Current 13.8 B USD +32.5%
Operating Lease, Liability, Noncurrent 294 M USD -14.8%
Other Liabilities, Noncurrent 3.99 B USD +0.23%
Liabilities 35.2 B USD +0.78%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.78 B USD -2.74%
Retained Earnings (Accumulated Deficit) -13.7 B USD -3.63%
Stockholders' Equity Attributable to Parent 7.28 B USD -7.41%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 7.54 B USD -11.3%
Liabilities and Equity 42.8 B USD -1.58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.39 B USD -7.03%
Net Cash Provided by (Used in) Financing Activities -1.36 B USD +38.1%
Net Cash Provided by (Used in) Investing Activities 931 M USD +37.7%
Common Stock, Shares Authorized 2.5 B shares 0%
Common Stock, Shares, Issued 1.24 B shares +0.98%
Common Stock, Par or Stated Value Per Share 0.1 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 815 M USD +64.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.99 B USD +37.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.08 B USD +13.7%
Deferred Tax Assets, Valuation Allowance 3.01 B USD -2.05%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.23 pure 0%
Deferred Tax Assets, Gross 1.81 B USD +24.3%
Operating Lease, Liability 417 M USD -5.66%
Depreciation 537 M USD -6.77%
Payments to Acquire Property, Plant, and Equipment 119 M USD -6.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -548 M USD +68.2%
Lessee, Operating Lease, Liability, to be Paid 496 M USD -8.66%
Property, Plant and Equipment, Gross 11.4 B USD +1.16%
Operating Lease, Liability, Current 320 M USD -8.31%
Lessee, Operating Lease, Liability, to be Paid, Year Two 98 M USD +4.26%
Lessee, Operating Lease, Liability, to be Paid, Year One 116 M USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -340 M USD +68.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 80 M USD +1.27%
Current Income Tax Expense (Benefit) 333 M USD -22.6%
Unrecognized Tax Benefits 651 M USD +2.04%
Lessee, Operating Lease, Liability, to be Paid, Year Four 62 M USD -6.06%
Operating Lease, Payments 141 M USD +0.71%
Additional Paid in Capital 27.8 B USD +0.28%
Amortization of Intangible Assets 603 M USD -13.5%
Interest Expense 1.03 B USD +10.6%